TTY Biopharm Co Ltd (4105) — Financial Flexibility Index
TTY Biopharm Co Ltd (4105) has a Financial Flexibility Index of 0.25x as of December 2025. Free cash flow of NT$813.61 Million (operating CF NT$778.89 Million minus capex NT$34.72 Million) represents 0% of total liabilities (NT$3.30 Billion). Check TTY Biopharm Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TTY Biopharm Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for TTY Biopharm Co Ltd across 9 annual periods. See TTY Biopharm Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for TTY Biopharm Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for TTY Biopharm Co Ltd. For the full company profile including market capitalisation, see market cap of TTY Biopharm Co Ltd.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | NT$1.91 Billion | NT$1.76 Billion | NT$3.30 Billion | ▲ +31.1% |
| 2024 | 0.44x | NT$1.48 Billion | NT$1.35 Billion | NT$3.35 Billion | ▲ +25.8% |
| 2023 | 0.35x | NT$1.18 Billion | NT$1.09 Billion | NT$3.37 Billion | ▼ -13.6% |
| 2022 | 0.41x | NT$1.37 Billion | NT$1.24 Billion | NT$3.37 Billion | ▲ +8.0% |
| 2021 | 0.38x | NT$1.33 Billion | NT$1.26 Billion | NT$3.53 Billion | ▲ +74.7% |
| 2020 | 0.22x | NT$708.21 Million | NT$526.35 Million | NT$3.28 Billion | ▼ -43.0% |
| 2019 | 0.38x | NT$1.28 Billion | NT$1.21 Billion | NT$3.38 Billion | ▼ -12.3% |
| 2018 | 0.43x | NT$1.15 Billion | NT$1.07 Billion | NT$2.66 Billion | ▲ +33.9% |
| 2017 | 0.32x | NT$1.09 Billion | NT$996.52 Million | NT$3.40 Billion | — |